ProQR Therapeutics Holds 2025 Annual Shareholder Meeting
Ticker: PRQR · Form: 6-K · Filed: Jun 3, 2025 · CIK: 1612940
| Field | Detail |
|---|---|
| Company | Proqr Therapeutics N.V. (PRQR) |
| Form Type | 6-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, corporate-governance, filing-update
TL;DR
ProQR held its 2025 shareholder meeting on June 3rd. All good.
AI Summary
ProQR Therapeutics N.V. held its 2025 annual general meeting of shareholders on June 3, 2025. The meeting took place at the offices of Allen Overy Shea. The filing is a Form 6-K, reporting for the month of June 2025.
Why It Matters
This filing confirms the completion of ProQR's annual shareholder meeting, a routine corporate event that signals ongoing operational and governance activities for the company.
Risk Assessment
Risk Level: low — This filing is a routine 6-K reporting the results of an annual general meeting, with no new financial or operational disclosures that would indicate increased risk.
Key Players & Entities
- ProQR Therapeutics N.V. (company) — Registrant
- June 3, 2025 (date) — Date of annual general meeting
- Allen Overy Shea (company) — Location of annual general meeting
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
When was the annual general meeting held?
The 2025 annual general meeting of shareholders was held on June 3, 2025.
Where was the annual general meeting held?
The meeting was held at the offices of Allen Overy Shea.
What is the company's principal executive office address?
The company's principal executive offices are located at Zernikedreef 9, 2333 CK Leiden, The Netherlands.
Does ProQR Therapeutics N.V. file annual reports under Form 20-F?
Yes, the company indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 3, 2025 regarding ProQR Therapeutics N.V. (PRQR).